GrantMatch.si

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Funder
National Institutes of Health
Award amount
Up to $1,500,000
Deadline
March 5, 2027
Eligible countries
United States

Summary

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Summary as listed on Grants.gov (opportunity 351847). Always read the full announcement for eligibility, limits and how to apply.

Read the full announcement on Grants.gov →

What National Institutes of Health reviewers look for

  • Importance of the research (significance and innovation), scored 1–9.
  • Rigor and feasibility of the approach, scored 1–9. Preliminary data and alternative strategies carry much of this.
  • Expertise and resources, rated sufficient or not, without a score.
  • Overall impact: the likelihood the project will have a sustained, powerful influence on its field.

Read our guide: what funded applications do →

See how this call matches your research

Build a free research profile and GrantMatch scores every open call against your work, tracks your deadlines and reminds you before they pass.

Get matched free